These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 29378721)

  • 21. Predicting Multidrug-Resistant Gram-Negative Bacterial Colonization and Associated Infection on Hospital Admission.
    Tseng WP; Chen YC; Yang BJ; Chen SY; Lin JJ; Huang YH; Fu CM; Chang SC; Chen SY
    Infect Control Hosp Epidemiol; 2017 Oct; 38(10):1216-1225. PubMed ID: 28870265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gram-negative infective endocarditis: a retrospective analysis of 10 years data on clinical spectrum, risk factor and outcome.
    Thomas VV; Mishra AK; Jasmine S; Sathyendra S
    Monaldi Arch Chest Dis; 2020 Nov; 90(4):. PubMed ID: 33190470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk Factors for Infection With Multidrug-Resistant Gram-Negative Bacteria in a Tertiary Care Hospital in Saudi Arabia: A Case-Control Study.
    Althaqafi A; Yaseen M; Farahat F; Munshi A; Al-Amri A; Essack SY
    Cureus; 2023 Apr; 15(4):e37291. PubMed ID: 37168219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High Rate of Multidrug-Resistant Gram-Negative Bacilli Carriage and Infection in Hospitalized Returning Travelers: A Cross-Sectional Cohort Study.
    Epelboin L; Robert J; Tsyrina-Kouyoumdjian E; Laouira S; Meyssonnier V; Caumes E;
    J Travel Med; 2015; 22(5):292-9. PubMed ID: 25997830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infective Endocarditis due to Non-HACEK Gram-Negative Bacilli: Clinical Characteristics and Risk Factors from a Prospective Multicenter Brazilian Cohort.
    de Sousa LP; Fortes CQ; Damasco PV; Barbosa GIF; Golebiovski WF; Weksler C; Garrido RQ; Siciliano RF; Lamas CDC
    Trop Med Infect Dis; 2023 May; 8(5):. PubMed ID: 37235331
    [No Abstract]   [Full Text] [Related]  

  • 26. Multidrug-Resistant Gram-Negative Bacterial Infections in the Hospital Setting: Overview, Implications for Clinical Practice, and Emerging Treatment Options.
    Cerceo E; Deitelzweig SB; Sherman BM; Amin AN
    Microb Drug Resist; 2016 Jul; 22(5):412-31. PubMed ID: 26866778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The respiratory threat posed by multidrug resistant Gram-negative bacteria.
    Rodrigo-Troyano A; Sibila O
    Respirology; 2017 Oct; 22(7):1288-1299. PubMed ID: 28681941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation and Characterization of Escherichia coli Sequence Type 131 and Other Antimicrobial-Resistant Gram-Negative Bacilli from Clinical Stool Samples from Veterans.
    Mohamed M; Clabots C; Porter SB; Thuras P; Johnson JR
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4638-45. PubMed ID: 27185805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of extensively drug-resistant gram negative bacilli in surgical intensive care in Egypt.
    Hasanin A; Eladawy A; Mohamed H; Salah Y; Lotfy A; Mostafa H; Ghaith D; Mukhtar A
    Pan Afr Med J; 2014; 19():177. PubMed ID: 25815098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pseudomonas aeruginosa infective endocarditis in patients who do not use intravenous drugs: Analysis of risk factors and treatment outcomes.
    Lin TI; Huang YF; Liu PY; Chou CA; Chen YS; Chen YY; Hsieh KS; Chen YS
    J Microbiol Immunol Infect; 2016 Aug; 49(4):516-22. PubMed ID: 25442867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results from a 13-Year Prospective Cohort Study Show Increased Mortality Associated with Bloodstream Infections Caused by Pseudomonas aeruginosa Compared to Other Bacteria.
    Thaden JT; Park LP; Maskarinec SA; Ruffin F; Fowler VG; van Duin D
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology and outcomes of non-HACEK infective endocarditis in the southeast United States.
    Veve MP; McCurry ED; Cooksey GE; Shorman MA
    PLoS One; 2020; 15(3):e0230199. PubMed ID: 32155223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study.
    Vasudevan A; Mukhopadhyay A; Li J; Yuen EG; Tambyah PA
    BMC Infect Dis; 2014 Nov; 14():615. PubMed ID: 25420613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of drug resistance in repeat gram-negative infections among patients with multiple hospitalizations.
    Agarwal M; Larson EL
    J Crit Care; 2018 Feb; 43():260-264. PubMed ID: 28946105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteremia: A retrospective propensity-matched case control study.
    Ting SW; Lee CH; Liu JW
    J Microbiol Immunol Infect; 2018 Oct; 51(5):621-628. PubMed ID: 28732563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surveillance culture for multidrug-resistant gram-negative bacteria: Performance in liver transplant recipients.
    Freire MP; Villela Soares Oshiro IC; Bonazzi PR; Pierrotti LC; de Oliveira LM; Machado AS; Van Der Heijdenn IM; Rossi F; Costa SF; Carneiro D'Albuquerque LA; Abdala E
    Am J Infect Control; 2017 Mar; 45(3):e40-e44. PubMed ID: 28254253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infective endocarditis in Turkey: aetiology, clinical features, and analysis of risk factors for mortality in 325 cases.
    Şimşek-Yavuz S; Şensoy A; Kaşıkçıoğlu H; Çeken S; Deniz D; Yavuz A; Koçak F; Midilli K; Eren M; Yekeler İ
    Int J Infect Dis; 2015 Jan; 30():106-14. PubMed ID: 25461657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends of 9,416 multidrug-resistant Gram-negative bacteria.
    Oliveira VD; Rubio FG; Almeida MT; Nogueira MC; Pignatari AC
    Rev Assoc Med Bras (1992); 2015; 61(3):244-9. PubMed ID: 26248247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enterococcal endocarditis in the beginning of the 21st century: analysis from the International Collaboration on Endocarditis-Prospective Cohort Study.
    Chirouze C; Athan E; Alla F; Chu VH; Ralph Corey G; Selton-Suty C; Erpelding ML; Miro JM; Olaison L; Hoen B;
    Clin Microbiol Infect; 2013 Dec; 19(12):1140-7. PubMed ID: 23517406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of fluoroquinolone administration on the emergence of fluoroquinolone-resistant gram-negative bacilli from gastrointestinal flora.
    Richard P; Delangle MH; Raffi F; Espaze E; Richet H
    Clin Infect Dis; 2001 Jan; 32(1):162-6. PubMed ID: 11112677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.